Recently Viewed
Clear AllQuality Score
0/0
Growth Score
0/0
Valuation Score
0/0
Bidding Date
21-Nov-2025 to
25-Nov-2025
Issue Size
₹895 Cr
Price Band
₹563 to ₹593
Allotment date
26-Nov-2025
Listing date
28-Nov-2025
Lot size
25
No. of shares
1,50,92,750
Fresh issue/OFS
₹95 Cr/₹800 Cr
Sudeep Pharma Ltd., founded in 1989 and headquartered in Vadodara, Gujarat, has established itself as a leading manufacturer of pharmaceutical excipients, food-grade minerals, and specialty nutrition ingredients serving more than 100 countries. Over the years, the company has evolved from producing basic mineral salts to a comprehensive portfolio spanning calcium, iron, magnesium, zinc, potassium, and sodium derivatives, focusing on the pharmaceutical, food, and nutrition sectors. With six manufacturing facilities and strong in-house R&D, Sudeep Pharma is recognized for its expertise in high-purity mineral salts, customized formulations, and robust quality assurance, supported by pilot-scale capabilities to foster innovation. Its customer base includes major Indian and international companies across pharma and nutrition, reflecting its adaptability to diverse compliance and formulation requirements in global markets. The company’s philosophy emphasizes continuous investment in technology and customer partnerships, prioritizing quality, traceability, and tailored solutions to address evolving industry and regulatory challenges.
Read our in-depth analysis of the Sudeep Pharma Ltd IPO Here
Category
Status
QIBs
4x
NIIs
32x
Retail
7.8x
Others
--
Total
11.9x
The issue size of Sudeep Pharma is ₹895.00 Cr.
Sudeep Pharma falls into Pharmaceuticals industry.
The Sudeep Pharma IPO will be listed on both NSE and BSE.
The open and close dates for the Sudeep Pharma are 21-Nov-2025 & 25-Nov-2025.
The price band for the Sudeep Pharma ipo is ₹563 to ₹593
The listing date of Sudeep Pharma IPO is 28-Nov-2025.
The purpose of this IPO is to raise fresh capital as well as enable the existing shareholders to sell their stake.
Sudeep Pharma total subscription ratio is 11.9X.
Key financial of the Sudeep Pharma are:
| Sudeep Pharma | FY-25 | FY-24 | FY-23 | FY-22 |
|---|---|---|---|---|
| Revenue (₹ Cr) | 502 | 459.28 | 428.74 | 343.01 |
| EBIT (₹ Cr) | 180.42 | 173.46 | 82.24 | 62.93 |
| Proft after Tax (₹ Cr) | 138.69 | 133.19 | 62.32 | 50.17 |
| Debt (₹ Cr) | 134.86 | 74.9 | 82.2 | 83.69 |
| Net Worth (₹ Cr) | 493.09 | 356.03 | 223.29 | 163.34 |
| RoE (%) | 28.13 | 37.41 | 27.91 | 30.71 |